Cardiology

In this article, we recap our top stories, expert interviews, and Q+A discussions from the 2025 Pediatric Academic Societies meeting.

Stealth BioTherapeutics' CEO stated, "We hope to gain more information on the revised action date in the coming days."

Do you know the details from the American Academy of Pediatrics' 2024 CCHD updated screening recommendations?

Submission is based on 3 clinical trials, including data from the ApproaCH Trial among children with achondroplasia.

Pediatric cancer survivors can be vulnerable to cardiovascular disease in the short- or long-term with increased recognition of cardiotoxic cancer treatments, as 5-year survival rates for children are greater than 85%.

An overview of commercially available infant cardiorespiratory monitors and pulse oximeters in the home.

Find out how you did on the quiz.

In this quiz, we test your knowledge of the AAP's new algorithm and updated recommendations for newborn screening for critical congenital heart disease.

In this quiz, we test your knowledge of the AAP's new algorithm and updated recommendations for newborn screening for critical congenital heart disease.

A review of current guidelines in treatment and thromboprophylaxis.

"The greatest risk reductions were demonstrated in those who experienced obesity remission during childhood," stated study authors.

The use of pulse oximetry screening for asymptomatic newborns at or around 24 hours of life helps identify at-risk infants.

A key update includes providing CPR with rescue breaths and chest compressions to all persons in cardiac arrest after water removal.

A study presented at the AAP 2024 National Conference & Exhibition finds Black infants are 40% more likely to die from congenital heart disease than White infants, highlighting persistent racial health disparities.

A pair of medical directors involved in the transplant clinical space provide commentary on heart and lung transplants in the pediatric population.

Compared with controls, children with CHD performed less well across all WISC-V indices and with large effect sizes for all indices and most subtests.

Findings indicate that chronically high stress markers could have a role in the development of EF impairments in early adolescents with cCHD.

A recent study suggests that high ultraprocessed food consumption in preschool children is linked to increased cardiometabolic risk factors.

Children with hypertension were at an increased risk of stroke, congestive heart failure, and other major adverse cardiac events compared to non-hypertensive individuals.

Even 6 years after publication, the investigative team stated it is unknown if the recommendations have led to changes in primary care.

“These findings suggest that primordial and primary interventions to prevent and reduce elevated childhood non–HDL-C levels may help prevent premature CVD," wrote the study authors.

The federal agency approved Perflutren Lipid Microsphere following positive data from 3 pediatric clinical trials.

Scott Ceresnak, MD, explains smartwatch technology could be a great tool in detecting arrhythmias in children, however, given that algorithms in the technology were designed for adults, caution must be used as well.

The Orphan Drug Designation follows the receipt of Rare Pediatric Disease Designation from the FDA in January 2024.

A real-world analysis in the United States suggests hospital volume may not be the lone predictor of outcomes in pediatric cardiac surgery.

Decreasing severe adverse safety events (ASEs) could improve the poor outcomes associated with children with out-of-hospital cardiac arrest (OHCA), since 60% had at least 1 ASE.

In a study that measured blood pressure (BP) in multiple stages of life until young adulthood, investigators concluded that lower BP levels early in life, maintained through young adulthood, could reduce the risk of cardiovascular disease (CVD).

In the 18 studies that assessed the efficacy of closing a patent ductus arteriosus after 1 course of acetaminophen treatments, the results demonstrated that both oral and IV preparations were more effective than placebo.

Timing of administration of epinephrine was not associated with survival to discharge for pediatric out-of-hospital cardiac arrest patients, but overall use of epinephrine was.